ClinicalTrials.Veeva

Menu

The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.

M

Medical University of Warsaw

Status and phase

Completed
Phase 4

Conditions

Diabetes Mellitus, Type 1

Treatments

Drug: Insulin Glulisine
Drug: Insulin Lispro
Drug: Insulin Aspart

Study type

Interventional

Funder types

Other

Identifiers

NCT04124302
Mixed Meal Bolus

Details and patient eligibility

About

The aim of the study is to compare the impact of two different insulin dose calculation on postprandial glycemia after mixed meal in children with type 1 diabetes mellitus.

Enrollment

76 patients

Sex

All

Ages

10 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • duration of type 1 diabetes longer than 12 months
  • insulin pump therapy longer than 3 months
  • treated by the same type of insulin longer than 3 months
  • written informed consent by patients and parents

Exclusion criteria

  • celiac disease
  • diabetes related complications (e.g. nephropathy)
  • any disease judged by the investigator to affect the trial
  • withdrawal of consent to participate in the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

76 participants in 2 patient groups

IPF
Active Comparator group
Description:
Total meal bolus will consist of insulin for carbohydrates (IC) and insulin for proteins and fats (IPF) based on individual insulin-to-carbohydrate ratio (ICR). Dual bolus will be given 15 minutes before the mixed meal (toast with cheese).
Treatment:
Drug: Insulin Aspart
Drug: Insulin Lispro
Drug: Insulin Glulisine
30%IC
Experimental group
Description:
Total meal bolus will consist of insulin for carbohydrates (IC) calculated based on individual insulin-to-carbohydrate ratio (ICR) and insulin for proteins and fats (IPF) estimated as 30% of IC. Dual bolus will be given 15 minutes before the mixed meal (toast with cheese).
Treatment:
Drug: Insulin Aspart
Drug: Insulin Lispro
Drug: Insulin Glulisine

Trial contacts and locations

1

Loading...

Central trial contact

Magdalena Dymińska, MD; Agnieszka Szypowska, Prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems